share_log

HC Wainwright & Co. Initiates Coverage On Blue Water Vaccines With Buy Rating, Announces Price Target of $7

HC Wainwright & Co. Initiates Coverage On Blue Water Vaccines With Buy Rating, Announces Price Target of $7

HC 溫賴特 & 有限公司.以購買評級啟動對藍水疫苗的覆蓋範圍,宣布目標價格為 7 美元
Benzinga Real-time News ·  2022/12/09 06:11

HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Blue Water Vaccines (NASDAQ:BWV) with a Buy rating and announces Price Target of $7.

HC 溫賴特公司分析師弗農貝納迪諾啟動了對藍水疫苗(NASDAQ:BWV)的「買入」評級的報導,並宣布目標價為 7 美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論